When would you consider glucocorticoids as adjunctive therapy for for community-acquired pneumonia outside of the ICU setting?
Has recent data showing mortality benefit in resource-limited settings swayed your practice?
Community PollStarted
Have you used glucocorticoids as adjunctive therapy for for community-acquired pneumonia outside of the ICU setting?
95 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet MemberInvited Expert
Hospital Medicine · UT Health San Antonio
Answered on · Updated on
Thank you for bringing this new study to my attention; I hadn't seen it yet.
After reviewing the article, my practice regarding steroids remains unchanged. While the trial was well-executed, and it is laudable to see such research coming out of a limited-resource setting, that environment differs si...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Hospital Medicine · Dartmouth-Hitchcock Medical Center
Answered on
We consider glucocorticoids for patients with severe community-acquired pneumonia. This is supported by the CAPE-COD trial and the Society of Critical Care Medicine (SCCM) guidelines, which provide moderate-certainty evidence showing reduced mortality (relative risk [RR] 0.62, 95% confidence interva...
Join for free or sign in to see the full answer